The entire cohort of 507 patients from the INCEPTION database were included, which consisted of HER2+ breast cancer patients being treated with trastuzumab and other cancer therapies including surgery, chemotherapy, and radiotherapy. The gene discussed is ERBB2; the disease is breast carcinoma.